Showing results (1231-1240 of 4,880) with videos related to
Sort By:
Pageof 488
Urologic Oncology|June 2, 2015
Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysisNaoya Niwa, Kazuhiro Matsumoto, Nozomi Hayakawa, et al.Urologic Oncology|June 10, 2015
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center studyGiovanni Lughezzani, Massimo Lazzeri, Nicolò Maria Buffi, et al.Urologic Oncology|June 16, 2015
Secondary malignant neoplasms in testicular cancer survivorsStephanie A Curreri, Chunkit Fung, Clair J BeardUrologic Oncology|June 20, 2015
State-of-the-art imaging of prostate cancerJamie Marko, C Frank Gould, Grant H Bonavia, et al.Urologic Oncology|June 20, 2015
Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chipJong Jin Oh, Seunghyun Park, Sang Eun Lee, et al.Urologic Oncology|June 22, 2015
The role of testis-sparing surgery in children and adolescents with testicular tumorsLynn L Woo, Jonathan H RossUrologic Oncology|June 22, 2015
Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinomaPranav Sharma, Kamran Zargar-Shoshtari, Jamie T Caracciolo, et al.Urologic Oncology|October 23, 2019
The miR-200 family as prognostic markers in clear cell renal cell carcinomaRola Saleeb, Sung Sun Kim, Qiang Ding, et al.Urologic Oncology|February 4, 2018
Furan and p-xylene as candidate biomarkers for prostate cancerAntonio Jiménez-Pacheco, María Salinero-Bachiller, María C Iribar, et al.Urologic Oncology|February 6, 2018
Designing a theory-based intervention to improve the guideline-concordant use of imaging to stage incident prostate cancerShannon Ciprut, Erica Sedlander, Kara L Watts, et al.Pageof 488